Global Bronchodilators Market 2017-2021

Publisher Name :
Date: 26-Jul-2017
No. of pages: 83
Inquire Before Buying

Bronchodilators are a type of medication, which make breathing easy by relaxing the muscles in the lungs and widening the airways (bronchi). They are used to treat the breathing problems, majorly asthma and COPD.

Short-acting bronchodilators are the first-line therapy, which is widely used in bronchodilators. These agents have a short-term (2-4 hours) duration of action and therefore require multiple dosages.

Whereas, long-acting bronchodilators, which are introduced recently, have an extended period of action. They reduce the process of multiple dosages. Therefore, they are more effective than the short-term bronchodilators.

The analysts forecast global bronchodilators market to grow at a CAGR of 4.78% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global bronchodilators market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Bronchodilators Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • AstraZeneca

  • Boehringer Ingelheim

  • F. Hoffmann-La Roche

  • GlaxoSmithKline


Other prominent vendors


  • ALK-Abello

  • Amgen

  • Array BioPharma

  • ASMACURE

  • Astellas Pharma

  • Atopix Therapeutics

  • CHIESI Farmaceutici

  • Dynavax Technologies

  • Kissei Pharmaceutical

  • Kyowa Hakko Kirin

  • MediciNova

  • Mitsubishi Tanabe Pharma

  • Mundipharma International

  • Nycomed Pharma

  • Oxagen

  • Pearl Therapeutics

  • Pharmaxis

  • Pulmagen Therapeutics

  • Regeneron Pharmaceuticals

  • Revalesio

  • Sanofi

  • SolAeroMed

  • Stallergenes Greer

  • sterna biologicals

  • Synairgen

  • Theron Pharmaceuticals

  • UCB Pharma

  • Verona Pharma


Market driver


  • Market potential toward mAb

  • For a full, detailed list, view our report


Market challenge


  • Increased preference for CAM

  • For a full, detailed list, view our report


Market trend


  • Innovative technologies for drug delivery

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Global Bronchodilators Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline

PART 05: Pipeline analysis

PART 06: Market landscape
Market overview
Five forces analysis

PART 07: Market segmentation by drug class
Anticholinergic bronchodilators
Adrenergic bronchodilators
Bronchodilator combinations
Methylxanthines

PART 08: Geographical segmentation
Bronchodilators market in Americas
Bronchodilators market in EMEA
Bronchodilators market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
Market drivers
Market challenges

PART 11: Market trends
Innovative technologies for drug delivery
Growing usage of home healthcare devices
Strong product pipeline

PART 12: Vendor landscape
Competitive scenario

PART 13: Key vendor analysis
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GlaxoSmithKline
Other prominent vendors

PART 14: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Types of bronchodilators
Exhibit 02: Pipeline landscape
Exhibit 03: Pipeline analysis
Exhibit 04: Usage of bronchodilators
Exhibit 05: Global bronchodilators market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis in global bronchodilators market
Exhibit 07: Five forces analysis
Exhibit 08: Global anticholinergic bronchodilators market 2016-2021 ($ millions)
Exhibit 09: Global adrenergic bronchodilators market 2016-2021 ($ millions)
Exhibit 10: Global bronchodilator combinations market 2016-2021 ($ millions)
Exhibit 11: Global methylxanthines bronchodilators market 2016-2021 ($ millions)
Exhibit 12: Global bronchodilators market based on geography 2016 and 2021 (%)
Exhibit 13: Bronchodilators market revenue by geography 2016-2021 ($ millions)
Exhibit 14: Market scenario in Americas
Exhibit 15: Bronchodilators market in Americas 2016-2021 ($ millions)
Exhibit 16: Market scenario in EMEA
Exhibit 17: Bronchodilators market in EMEA 2016-2021 ($ millions)
Exhibit 18: Market scenario in APAC
Exhibit 19: Bronchodilators market in APAC 2016-2021 ($ millions)
Exhibit 20: Recent approvals in mAb for bronchodilators market
Exhibit 21: Drugs expected to get approval in forecast period
Exhibit 22: Recent approvals in bronchodilators market
Exhibit 23: Drug approvals in COPD drugs market in past three years
Exhibit 24: COPD drug molecules in the stage of registration
Exhibit 25: Competitive structure analysis of global bronchodilators market 2016
Exhibit 26: Strategic success factors of companies in global bronchodilators market
Exhibit 27: AstraZeneca: Strength assessment
Exhibit 28: AstraZeneca: Strategy assessment
Exhibit 29: AstraZeneca: Opportunity assessment
Exhibit 30: Boehringer Ingelheim: Strength assessment
Exhibit 31: Boehringer Ingelheim: Strategy assessment
Exhibit 32: Boehringer Ingelheim: Opportunity assessment
Exhibit 33: F. Hoffmann-La Roche: Strength assessment
Exhibit 34: F. Hoffmann-La Roche: Strategy assessment
Exhibit 35: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 36: GlaxoSmithKline: Strength assessment
Exhibit 37: GlaxoSmithKline: Strategy assessment
Exhibit 38: GlaxoSmithKline: Opportunity assessment

  • Global Montelukast Sodium Market Professional Survey Report 2018
    Published: 15-Feb-2018        Price: US 3500 Onwards        Pages: 116
    This report studies Montelukast Sodium in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Morepen Laboratories - Mylan - TAPI - MSN Laboratories - U......
  • 2015-2023 World Doxofylline (API) Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 14-Feb-2018        Price: US 2800 Onwards        Pages: 119
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • China Bronchodilator Market Research Report 2018
    Published: 05-Feb-2018        Price: US 3400 Onwards        Pages: 108
    The global Bronchodilator market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Bronchodilator development status and future trend in China, focuses on top players in China, also splits Bronchodilator b......
  • Global Asthma Partnering 2012 to 2018
    Published: 01-Feb-2018        Price: US 1495 Onwards        Pages: 100
    ""Delivery of this report will take 1-3 days after purchase."" The Global Asthma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understand......
  • Zenhale - Drug Insights
    Published: 31-Jan-2018        Price: US 1000 Onwards        Pages: 35
    Introduction DelveInsight's pharmaceuticals report, "Zenhale Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Zenhale covering the historical global sales and also provides the Zenhale sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, ......
  • Asthma - Epidemiology Forecast to 2027
    Published: 31-Jan-2018        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Asthma - Epidemiology Forecast, 2027" report provides a comprehensive analysis of the Asthma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Asthma Epidemiology The epidemiology section covers the historical, current as......
  • Asthma - Market Insight, Epidemiology and Market Forecast - 2027
    Published: 31-Jan-2018        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "Asthma - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Asthma epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Asthma Understanding and Treatment Algorithm The market report provides the overview of the Asthma by providing the disease ......
  • Singulair Paediatric - Drug Insights
    Published: 31-Jan-2018        Price: US 1000 Onwards        Pages: 35
    Introduction DelveInsight's pharmaceuticals report, "Singulair Paediatric Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Singulair Paediatric covering the historical global sales and also provides the Singulair Paediatric sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market......
  • Nucala - Drug Insights
    Published: 31-Jan-2018        Price: US 1000 Onwards        Pages: 35
    Introduction DelveInsight's pharmaceuticals report, "Nucala Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Nucala covering the historical global sales and also provides the Nucala sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, mar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs